Cargando…

Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques

The management of patients with thyroid cytopathologic diagnosis of atypia (or follicular lesion) of undetermined significance (AUS/FLUS) is a complex clinical problem. The purpose of this study was to develop a practical triage scheme based on multiple diagnostic tests in general use. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hyuk, Jeong, Dae Joon, Hahn, Soo Yeon, Shin, Jung Hee, Oh, Young Lyun, Ki, Chang‐Seok, Kim, Jong‐Won, Jang, Ju Young, Cho, Yoon Young, Chung, Jae Hoon, Kim, Sun Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864806/ https://www.ncbi.nlm.nih.gov/pubmed/26775803 http://dx.doi.org/10.1002/cam4.636

Ejemplares similares

Clinicopathological factors increased the risk of malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS
por: Hong, In Ki, et al.
Publicado: (2016)

Diagnostic Thyroidectomy May Be Preferable in Patients With Suspicious Ultrasonography Features After Cytopathology Diagnosis of AUS/FLUS in the Bethesda System
por: Lee, Yong Sang, et al.
Publicado: (2015)

Rate of malignancy for thyroid nodules with AUS/FLUS cytopathology in a tertiary care center – a retrospective cohort study
por: Hathi, Kalpesh, et al.
Publicado: (2021)

The Diagnostic Performance of Thyroid US in Each Category of the Bethesda System for Reporting Thyroid Cytopathology
por: Park, So Yoon, et al.
Publicado: (2016)

Editorial: Subclassification of AUS/FLUS category for thyroid nodules: trials and evidence-based clinical management
por: Bayraktaroğlu, Taner, et al.
Publicado: (2023)

Assessment of Preoperative TSH Serum Level and Thyroid Cancer Occurrence in Patients with AUS/FLUS Thyroid Nodule Diagnosis
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation
por: Huhtamella, Roope, et al.
Publicado: (2019)

Thyroid Bethesda Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance (AUS/FLUS): A Heterogenous Group
por: Maity, Priyanka, et al.
Publicado: (2019)

RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAF(V600E) Mutation-Negative Nodules?
por: Yoon, Jung Hyun, et al.
Publicado: (2015)

Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size
por: Kim, Hye In, et al.
Publicado: (2017)

The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk
por: Alshahrani, Awad S, et al.
Publicado: (2021)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
por: Lee, You-Bin, et al.
Publicado: (2018)

Birds, Pigs, and People: The Rise of Pandemic Flus
por: Walters, Mark Jerome
Publicado: (2014)

Comparison of clinicopathological characteristics and survival between symptomatic and asymptomatic anaplastic thyroid carcinoma
por: Cho, Seomin, et al.
Publicado: (2023)

Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study
por: Lee, You-Bin, et al.
Publicado: (2021)

Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
por: Kim, Hosu, et al.
Publicado: (2019)

Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
por: Park, Hyunju, et al.
Publicado: (2021)

BCR‐ABL1 transcript levels at 4 weeks have prognostic significance for time‐specific responses and for predicting survival in chronic‐phase chronic myeloid leukemia patients treated with various tyrosine kinase inhibitors
por: Song, Hye‐young, et al.
Publicado: (2018)

Clinico‐cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long‐term clinical follow‐up
por: Song, Min Jeong, et al.
Publicado: (2021)

What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography?
por: Kim, Haejung, et al.
Publicado: (2022)

Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy
por: Park, Hyunju, et al.
Publicado: (2023)

LBODP092 Proposal Of Indication For Completion Thyroidectomy In Follicular Thyroid Carcinoma Using TERT Promoter Mutational Status
por: Park, Hyunju, et al.
Publicado: (2022)

Cancer cytopathology.
Publicado: (1997)

Identification of a Rare 3 bp BRAF Gene Deletion in a Thyroid Nodule by Mutant Enrichment with 3'-Modified Oligonucleotides Polymerase Chain Reaction
por: Jang, Mi-Ae, et al.
Publicado: (2012)

Multimodal MRI-Based Triage for Acute Stroke Therapy: Challenges and Progress
por: Bang, Oh Young, et al.
Publicado: (2018)

Clinical and cytopathological characteristics of HTLV‐1(+) hodgkin lymphoma
por: Kobata, Katsumi, et al.
Publicado: (2020)

Discrepancies between the ultrasonographic and gross pathological size of papillary thyroid carcinomas
por: Hahn, Soo Yeon, et al.
Publicado: (2016)

Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
por: Heo, Jung, et al.
Publicado: (2023)

Evaluation of Modified Core-Needle Biopsy in the Diagnosis of Thyroid Nodules
por: Ahn, Soomin, et al.
Publicado: (2018)

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
por: Park, Jun, et al.
Publicado: (2021)

Review of thyroid cytopathology: An atlas and text
por: Flanagan, Melina, et al.
Publicado: (2008)

Thyroid cytopathology: updates and molecular testing
por: Vance, J., et al.
Publicado: (2019)

Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status
por: Park, Hyunju, et al.
Publicado: (2023)

Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
por: Park, Jun, et al.
Publicado: (2021)

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway
por: Kim, Se Lim, et al.
Publicado: (2022)

Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population
por: Cho, Yoon Young, et al.
Publicado: (2020)

Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types
por: Cho, Jooyeon, et al.
Publicado: (2018)

Ultrasonographic characteristics of Hürthle cell neoplasms: prediction of malignancy
por: Kim, Min Je, et al.
Publicado: (2022)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aafd72kam4l53ar4b57c73nkim